Published in Elife on May 07, 2015
Transparent reporting of research results in eLife. Elife (2016) 0.97
Nextflow enables reproducible computational workflows. Nat Biotechnol (2017) 0.92
Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? Hum Reprod Update (2015) 0.79
Reproducibility and transparency in biomedical sciences. Oral Dis (2016) 0.75
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Publication bias in clinical research. Lancet (1991) 22.85
Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov (2011) 22.33
Drug development: Raise standards for preclinical cancer research. Nature (2012) 20.64
Policy: NIH plans to enhance reproducibility. Nature (2014) 15.71
Avoidable waste in the production and reporting of research evidence. Lancet (2009) 12.28
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
Increasing value and reducing waste in research design, conduct, and analysis. Lancet (2014) 6.07
Biomedical research: increasing value, reducing waste. Lancet (2014) 5.39
Reducing waste from incomplete or unusable reports of biomedical research. Lancet (2014) 5.37
A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 5.36
Reproducibility. Science (2014) 4.11
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA (1999) 3.07
How to make more published research true. PLoS Med (2014) 2.55
Six red flags for suspect work. Nature (2013) 2.51
An open investigation of the reproducibility of cancer biology research. Elife (2014) 2.43
Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat Protoc (2012) 2.14
The increasing urgency for standards in basic biologic research. Cancer Res (2014) 1.87
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med (2012) 1.85
Minimum Information About a Microarray Experiment (MIAME)--successes, failures, challenges. ScientificWorldJournal (2009) 1.76
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Learning from our GWAS mistakes: from experimental design to scientific method. Biostatistics (2012) 1.35
Retraction. Science (2011) 1.32
Time to do something about reproducibility. Elife (2014) 1.16
Journals should publish all "null" results and should sparingly publish "positive" results. Cancer Epidemiol Biomarkers Prev (2006) 1.05
Assessing individual agreement. J Biopharm Stat (2007) 0.99
The practical effect of batch on genomic prediction. Stat Appl Genet Mol Biol (2012) 0.99
Prospective registration of marker evaluation studies: time to act. Clin Chem (2011) 0.85
The time has come to register diagnostic and prognostic research. Clin Chem (2014) 0.83
Breakthrough articles: putting science first. Nucleic Acids Res (2014) 0.77
Transparent reporting of research results in eLife. Elife (2016) 0.97
Clinical- and cost-effectiveness of a nurse led self-management intervention to reduce emergency visits by people with epilepsy. PLoS One (2014) 0.88
Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention. PLoS One (2016) 0.75